Notice of Change of Key Dates for RFA-HL-18-025 "Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03 - Clinical Trial Optional)"

Notice Number: NOT-HL-17-557

Key Dates
Release Date: November 3, 2017  

Related Announcements
RFA-HL-18-025  

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that an additional due date has been added to RFA-HL-18-025 "Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03 Clinical Trial Optional)". This additional application due date is in response to the early expiration of RFA-HL-16-020. The Key Dates section of RFA-HL-18-025 has been revised as presented below, with additions emphasized in bold.   

Part 1. Key Dates

 

Currently reads: 

Posted Date

October 6, 2017

Open Date (Earliest Submission Date)

January 15, 2018

Letter of Intent Due Date(s)

30 days prior to the application due date

Application Due Date(s)

February 15, 2018; June 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

June 2018, October 2018

Advisory Council Review

August 2018, October 2019

Earliest Start Date

September 2018, April 2019

Expiration Date

September 8, 2018

Modified to read:
  


Posted Date

October 6, 2017

Open Date (Earliest Submission Date)

January 15, 2018

Letter of Intent Due Date(s)

30 days prior to the application due date

Application Due Date(s)

February 15, 2018; June 14, 2018; October 17, 2018 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

June 2018, October 2018, March 2019

Advisory Council Review

August 2018, January 2019, May 2019

Earliest Start Date

September 2018, April 2019, July 2019

Expiration Date

January 8, 2019

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)
Lisbeth Welniak, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8297
Email: welniakla@mail.nih.gov

Peer Review Contact(s)
Director, Office of Scientific Review
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0270
Email: nhlbichiefreviewbranch@nhlbi.nih.gov

Financial/Grants Management Contact(s)
Mykle Lyons
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8043
Email: mykle.lyons@nih.gov